|
Chris MacLeod is a Partner in the law firm Cambridge LLP, www.cambridgellp.com. He also has Cystic Fibrosis and chairs the Canadian Cystic Fibrosis treatment Society. He talks about his life as a prominent lawyer living with cystic fibrosis and his work as the chair of the Society. He explains his success in advocating for recognition of the new cystic fibrosis medication, Kalydeca. He describes what he sees as most challenging of the challenges associated with access, disparity, and inequity as these relate to medications of demonstrable value in the treatment of cystic fibrosis. He highlight
|
